posts browsing tag

macrogen

– Export of test kit to entire Europe and numerous countries that recognize CE-IVD gains impetus – Awaiting to sign supply agreements with numerous countries in Europe, Latin America, Southeast Asia and the Middle East The Korean biotech company Macrogen (CEO Sukang Lee), announced on the 3rd that it …

Continue reading

The Korean biotech company Macrogen (CEO Sukang Lee) (KOSDAQ: 038290), announced that it obtained export approval for the COVID-19 test kit ‘AxenTM COVID-19 RT’ from the Ministry of Food and Drug Safety (MFDS) on the 18th.  Macrogen’s COVID-19 test kit is a product that uses RT …

Continue reading

As the molecular road map and blueprint of human biology, a single genome contains all the information required to build, maintain and repair a human being. Since the successful mapping of the human genome in 2003, mankind’s elevated understanding of how approximately 3 billion base pairs of deoxyribonucleic acid …

Continue reading

ROCKVILLE, MD–On January 2nd, the Psomagen–Macrogen Consortium announced the acquisition of all key assets of US company uBiome. Through the move, Psomagen has become a key player in the microbiome sector, a promising next-generation bio healthcare industry, with a competitive advantage in the US and …

Continue reading

– The largest number of regions and races included in any Asian reference panel – Identification of genome diversity within Asian ethnic groups and differences in drug response SEOUL, South Korea–The precision medicine and biotechnology company Macrogen (Chairman Jung-Sun Seo) (KOSDAQ: 038290) announced on Dec 4 that …

Continue reading